PLANTATION, FL, March 23, 2020 /PRNewswire/ - Akumin Inc. (TSX:
AKU.U, AKU) ("Akumin") announced today it will be dedicating 10 of
its freestanding, outpatient diagnostic imaging centers (the
"Designated Centers") across its regions to focus specifically on
patients who have been diagnosed with an active case of COVID-19,
the disease caused by the novel coronavirus, or who have similar
symptoms. Those patients can receive imaging procedures, such as
CT, X-ray or Ultrasound, to the extent they have been ordered by a
physician who determines such services to be necessary or useful in
connection with their medical assessment and treatment related to
COVID-19. This decision will also allow such patients to receive
essential medical imaging studies which may be necessary in
connection with COVID-19 or other conditions unrelated to COVID-19.
While Akumin continues to follow CDC and state and local health
department guidelines relating to infectious disease protocols at
all of its centers to protect its patients, personnel and the
broader community, the Designated Centers will maintain heightened
decontamination protocols.
"Akumin is taking these actions to do its part to help its
communities in response to COVID-19 by dedicating healthcare
resources to dealing with this pandemic while ensuring the safety
of its employees and patients," said Riadh
Zine, CEO of Akumin.
All other Akumin imaging centers remain open to provide imaging
services for our patients, subject to local laws and compliance
with CDC guidelines. These imaging centers will continue to screen
patients before entry, based on CDC guidelines, and will direct
symptomatic patients to the Designated Centers. In addition, Akumin
will work with local health authorities to provide an alternative
imaging option to hospital essential imaging services so that
resources at hospitals can be focused on, and redirected to dealing
with, the coronavirus outbreak. Also, subject to local public
health orders intended to fight the novel coronavirus and preserve
personal protective equipment, Akumin patients with scheduled
screening studies may experience a deferral of their studies.
The Designated Centers will, starting March 25, 2020, initially include the following
locations:
Locations
|
Address
|
Telephone
|
Florida – Akumin
Fleming Island
|
4565 US Hwy 17 South,
Ste 150
Fleming Island, FL 32003
|
(904)
592-4700
|
Florida – Akumin
Maitland
|
7960 Forest City Rd
Ste 102
Orlando, FL 32810-2938
|
(407)
544-3451
|
Florida – Akumin
North Miami
|
88 NE 168th St
North Miami Beach, FL 33162-3410
|
(305)
770-4343
|
Florida – Akumin St
Petersburg
|
3451 66th St N Ste
B
Saint Petersburg, FL 33710-1568
|
(727)
347-4674
|
Florida – Akumin
Tampa
|
5107 N Armenia
Ave
Tampa, FL 33603-1405
|
(813)
637-2906
|
Florida – Akumin
Weston
|
2229 N Commerce Pkwy
Ste 150
Weston, FL 33326-3239
|
(954)
349-0054
|
Pennsylvania – Akumin
Grant
|
1619 Grant Ave Ste
10
Philadelphia, PA 19115-3161
|
(215)
934-6100
|
Pennsylvania – Akumin
Haverford
|
600 E Township Line
Rd
Havertown, PA 19083-5716
|
(610)
446-1800
|
Texas – Akumin
Denton
|
1614 Scripture St Ste
2
Denton, TX 76201-3838
|
(940)
387-6159
|
Texas – Akumin
Mesquite
|
2540 N Galloway Ave
Ste 202
Mesquite, TX 75150-4813
|
(972)
681-6340
|
Patients are encouraged to check www.akumin.com prior to their
appointment to confirm current facility status and scheduling.
About Akumin
Akumin is a leading provider of outpatient diagnostic imaging
services in the United States,
with freestanding centers located in Florida, Texas, Pennsylvania, Delaware, Georgia, Illinois and Kansas. Our centers provide physicians with
imaging capabilities to facilitate the diagnosis and treatment of
diseases and disorders, thereby reducing the need for unnecessary
invasive procedures and contributing to lower costs and better
outcomes for patients. Our imaging procedures include magnetic
resonance imaging (MRI), computerized tomography (CT), positron
emission tomography (PET), ultrasound, X-ray, mammography and other
diagnostic or interventional radiology procedures.
Forward-Looking Information
Certain information in this press release constitutes
forward-looking information. In some cases, but not necessarily in
all cases, forward-looking information can be identified by the use
of forward-looking terminology such as "plans", "targets",
"expects" or "does not expect", "is expected", "an opportunity
exists", "is positioned", "estimates", "intends", "assumes",
"anticipates" or "does not anticipate" or "believes", or variations
of such words and phrases or state that certain actions, events or
results "may", "could", "would", "might", "will" or "will be
taken", "occur" or "be achieved". In addition, any statements that
refer to expectations, projections or other characterizations of
future events or circumstances contain forward-looking information.
Statements containing forward-looking information are not
historical facts but instead represent management's expectations,
estimates and projections regarding future events.
Forward-looking information is necessarily based on a number of
opinions, assumptions and estimates that, while considered
reasonable by Akumin as of the date of this press release, are
subject to known and unknown risks, uncertainties, assumptions and
other factors that may cause the actual results, level of activity,
performance or achievements to be materially different from those
expressed or implied by such forward-looking information, including
but not limited to the factors described in greater detail in the
"Risk Factors" section of our Annual Information Form dated
March 28, 2019, which is available at
www.sedar.com. These factors are not intended to represent a
complete list of the factors that could affect Akumin; however,
these factors should be considered carefully. There can be no
assurance that such estimates and assumptions will prove to be
correct. The forward-looking statements contained in this press
release are made as of the date of this press release, and Akumin
expressly disclaims any obligation to update or alter statements
containing any forward-looking information, or the factors or
assumptions underlying them, whether as a result of new
information, future events or otherwise, except as required by
law.
View original
content:http://www.prnewswire.com/news-releases/akumin-designates-imaging-centers-for-covid-19-response-301027988.html
SOURCE Akumin Inc.